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Ten-Eleven Translocation (Tet) family of dioxyge-
nases dynamically regulates DNA methylation and
has been implicated in cell lineage differentiation
and oncogenesis. Yet their functions and mecha-
nisms of action in gene regulation and embryonic
development are largely unknown. Here, we report
that Xenopus Tet3 plays an essential role in early
eye and neural development by directly regulating
a set of key developmental genes. Tet3 is an active
5mC hydroxylase regulating the 5mC/5hmC status
at target gene promoters. Biochemical and structural
studies further demonstrate that the Tet3 CXXC
domain is critical for specific Tet3 targeting. Finally,
we show that the enzymatic activity and CXXC
domain are both crucial for Tet3’s biological function.
Together, these findings define Tet3 as a transcrip-
tion regulator and reveal a molecular mechanism by
which the 5mC hydroxylase and DNA binding activi-
ties of Tet3 cooperate to control target gene expres-
sion and embryonic development.
INTRODUCTION
The process of vertebrate development is established through
the integration of several molecular pathways controlled by key1200 Cell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc.regulatory genes and complex epigenetic markings. DNA meth-
ylation at the 5-position of cytosine (5mC) is a key epigenetic
mark playing crucial roles in vertebrate development (Bestor
and Coxon, 1993; Bird, 1986; Reik et al., 2001). Recent studies
have demonstrated that the Tet family of 5mC hydroxylases
can catalyze the conversion of 5mC to 5-hydroxymethylcytosine
(5hmC) (Tahiliani et al., 2009) and further to 5-formylcytosine
(5fC) and 5-carboxylcytosine (5CaC) (He et al., 2011; Ito et al.,
2011). These studies also suggest that additional modification
of 5mC modulated by Tet enzymes may regulate the dynamics
of 5mC and its mediated gene regulation (Branco et al., 2012).
Themammalian Tet family has threemembers, Tet1, Tet2, and
Tet3. It has been suggested that both Tet1 and Tet2 play impor-
tant roles in ES cell lineage specification (Ito et al., 2010; Koh
et al., 2011) and that Tet1 regulates DNA methylation and gene
expression in mouse ES cells (Ficz et al., 2011; Williams et al.,
2011; Wu et al., 2011; Xu et al., 2011b). Mutational inactivation
of TET2 has been reported to associate with decreased 5hmC
levels in various myeloid leukemias (Delhommeau et al., 2009;
Langemeijer et al., 2009), and Tet2 deficiency leads to increased
hematopoietic stem cell self-renewal and myeloid transfor-
mation in mouse (Moran-Crusio et al., 2011; Quivoron et al.,
2011). Recently, we and others also show that TET1 and TET2
play critical roles in other human cancers, such as melanoma
and breast cancer (Hsu et al., 2012; Lian et al., 2012). In addition,
Tet3 is the only Tet family member highly expressed in mouse
oocytes and zygotes and is responsible for the hydroxylation
of 5mC that occurs in the paternal pronucleus of advanced
pronuclear-stage zygotes (Gu et al., 2011; Iqbal et al., 2011;
Wossidlo et al., 2011). Conditional knockout of Tet3 in mouse
oocytes prevents resetting of DNA methylation patterns in
zygotes and impairs reprogramming of transferred somatic
nuclei (Gu et al., 2011). Nevertheless, Tet3/ knockout mice
are viable through development, but die on postnatal day one
(Gu et al., 2011). Taken together, although the discovery of the
Tet family of 5mC hydroxylases provides a potential mechanism
for the dynamic regulation of DNAmethylation, it remains unclear
how Tet proteins are recruited to and regulate the expression of
target genes, thereby providing linkage to their specific functions
in early vertebrate embryonic development.
Although all Tet family members contain a conserved
C-terminal catalytic domain, only Tet1 and Tet3 contain the
CXXC domain, a potential DNA binding module characterized
by two CXXCXXC repeats. The CXXC domains, found in other
proteins such as DNMT1, MLL, and CFP1, have been shown to
specifically bind to unmethylated CpG dinucleotides and partic-
ipate in gene transcription regulation (Allen et al., 2006; Pradhan
et al., 2008; Xu et al., 2011a). Although our previous study has
suggested an important role of the CXXC domain in targeting
Tet1 enzyme to specific genomic regions in ES cells (Xu et al.,
2011b), the molecular mechanism and biological importance of
this domain in Tet1- and Tet3-mediated transcriptional regula-
tion of target genes remain largely unknown.
In this report, we characterize the molecular and biochemical
properties and the biological function of Tet3 by using Xenopus
as a model. Our study shows that Tet3 is essential for early
eye and neural development in Xenopus. We also demon-
strate that several master control genes essential for eye and
neural development are Tet3’s direct targets, mechanistically
linking Tet3 function in transcriptional regulation of these key
genes to the developmental phenotypes caused by Tet3 deple-
tion. Using structural and mutational analyses and functional
rescue approaches, we show that Tet3’s 5mC hydroxylase
and the CXXC domain-mediated DNA binding activities coop-
erate to regulate target gene expression during eye and neural
development.
RESULTS
Identification and Characterization of Xenopus Tet3
Gene Reveal that Tet3 Is Essential for Early Eye and
Neural Development
To understand the biological function of Tet proteins in early
embryonic development, we investigated Tet family members
in Xenopus. Database searches reveal two Tet orthologs in Xen-
opus tropicalis, Tet2 and Tet3, but not Tet1 (Figure S1A available
online). We cloned Xenopus laevis Tet3 (xlTet3) gene and subse-
quently discovered two xlTet3 isoforms (HQ220207-xlTet3a and
HQ220208-xlTet3b) that exhibit greater than 90% amino acid
similarity to xtTet3 (Figure S1A). Surprisingly, despite extensive
searching, we were unable to identify a Tet1 ortholog in either
X. tropicalis or X. laevis. We, therefore, conclude that the Xeno-
pus genome contains only two Tet-related genes, Tet2 and
Tet3, and lacks a Tet1 gene. Sequence analysis reveals that
similar to mammalian Tet3 proteins (which we cloned, validated,
and deposited into GeneBank; HQ220209, human TET3; and
HQ423151, mouse Tet3), Xenopus Tet3 contains a CXXCdomain, a cysteine-rich domain and a double-stranded b helix
(DSBH)-containing dioxygenase domain (Figure S1A).
We next examined the expression profile of xlTet3 during
embryogenesis. The temporal expression pattern of xlTet3 by
RT-qPCR reveals that, unlike the high level of Tet3 mRNA
observed in mouse oocytes (Gu et al., 2011; Iqbal et al., 2011;
Wossidlo et al., 2011), the xlTet3 mRNA level in oocytes is very
low. xlTet3 mRNA is also barely detectable at stage 2 (2-cell
stage) through stage 7, but increases dramatically from stage 9
(immediately after the initiation of zygotic transcription) to stage
19 and then drops at stage 25 (Figure S1B). The spatial expres-
sion pattern of xlTet3 by in situ hybridization shows that xlTet3
mRNA is barely detectable at stage 9 (Figure 1A), but clearly de-
tected by stage 14 in the neural plate (Figure 1B). In embryo
sections, we also detect xlTet3 mRNA in the neural plate and
notochord (Figures S1C and S1D). Moreover, xlTet3mRNA level
remains high in the neural tube at stage 19 (Figure 1C) and in the
region of the developing brain, eye, branchial arches, cement
gland, and spinal cord at stage 25 (Figures 1D and 1E).
To address Tet3 function during embryogenesis, we per-
formed loss-of-function studies by depleting endogenous xlTet3
protein by using the Morpholino antisense oligo (MO) strategy.
We first confirmed that xlTet3 MOs efficiently deplete Tet3
protein (Figure 1F). Control MO or xlTet3 MOs were injected
into two dorsal blastomeres of 4-cell stage embryos. At stage
35, we observe striking developmental abnormalities in 96%
(194/201) of xlTet3 MOs-injected embryos, including malforma-
tion of the eye (eyeless), small head, and missing pigmentation
along the lateral body, whereas control embryos develop nor-
mally (Figure 1G). The Tet3-depleted embryos die between
stages 35 and 40. Importantly, these phenotypes are rescued
by coinjecting the xlTet3MOs-resistant xtTet3mRNA (Figure 1G,
right). Taken together, these data suggest that Tet3 plays an
essential role in early embryogenesis, especially in early eye
and neural development.
Tet3 Directly Regulates a Set of Genes Critical for Eye
and Neural Development
To gain insight into the underlying molecular mechanisms linking
Tet3 function to early eye and neural development, we examined
the effect of Tet3 depletion on the expression of a set of key
developmental genes, including pax6 (eye and neural marker),
rx and six3 (eye markers), sox2 (pan-neural marker), otx2 (ante-
rior neural marker), sox9 and snail (neural crest markers), neuro-
genin related 1 (ngn2) and n-tubulin (tubb2b) (primary neuron
markers), and shh and ptc-1 (sonic hedgehog signaling) in stage
14 embryos. MOs were injected into one dorsal blastomere of
4-cell stage embryos so that the uninjected side could be used
as an internal control. For shh and ptc-1 measurement, we in-
jected MOs into two dorsal blastomeres of 4-cell stage embryos
because the expression of shh and ptc-1 is in the midline. As
shown by in situ hybridization, the expression of master eye
developmental genes, pax6, rx, and six3, is greatly reduced on
the xlTet3 MOs-injected side compared to the uninjected side
at stage 14 (Figure 2A). Reduced expression of these eye genes
is also seen in the potential eye field on the Tet3-depleted side at
stage 19 (Figure S2A). Depletion of Tet3 also inhibits the expres-
sion of two primary neuron markers, ngn2 and tubb2b, and twoCell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc. 1201
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Figure 1. Tet3 Is Important for Early Eye and Neural Development
(A–E) Spatial expression profile of xlTet3 by in situ hybridization at stage 9 (A), 14 (B), 19 (C), and 25 (D and E). The sites of sections I and II in (E) are noted by red
dashed lines in (D). Animal view (an), vegetal view (v), dorsal view (d), lateral view (L), brain (b), eye (e), cement gland (c), branchial arches (ba), and spinal cord (sc).
(F) Western blot showing depletion of endogenous Tet3 protein by xlTet3 MOs in stage 14 embryos.
(G) Developmental defects in stage 35 embryos caused by Tet3 depletion. Small head, eyeless, and missing pigmentation phenotypes in xlTet3 MOs-injected
embryos are noted by red arrows, and the normal pigmentation in control embryos is noted by a black arrow.
See also Figure S1.neural crest markers, sox9 and snail, supporting a critical role of
Tet3 in neural and neural crest development (Figure 2A). The
expression of two major shh signaling components, shh and
ptc-1, is also abolished in Tet3-depleted embryos at stage 14
(Figure 2A), whereas the expression of otx2 and sox2 shows no
significant changes (Figure S2B). Importantly, the diminished
expression of all affected genes is rescued by xtTet3 mRNA
coinjection (Figure 2A), demonstrating the specific regulation
of these genes by Tet3. Results by in situ hybridization are fur-
ther independently confirmed by RT-qPCR assays (Figures 2B
and S2C).
To address whether Tet3 directly regulates these key
genes, we performed chromatin immunoprecipitation (ChIP)
assays. We employed an epitope-tagged ChIP assay by using
Flag antibody and flag-xtTet3 mRNA-injected embryos to
explore Tet3 occupancy at the promoters of these genes. We
detect strong Tet3 binding at the promoters of pax6, rx, six3,
ptc-1, ptc-2, sox9, and ngn2 but not at the promoters of control
genes, myosin light chain 2 (myl2), and cardiac actin (actc)
(Figure 2C).
Finally, we tested whether ectopic expression of any one of
these downstream Tet3 target genes can rescue the phenotypes1202 Cell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc.caused by Tet3 depletion. We examined the rescue effects of
pax6, rx, or shh overexpression. As shown in Figure S2D, none
of these can rescue the phenotypes, suggesting that it may be
the cumulative effect of the altered expression of a group of
target genes, rather than a single gene, that causes the observed
developmental defects. Nevertheless, our data strongly suggest
that Tet3 is an upstream transcriptional regulator specifically and
directly controlling a set of key genes important for early eye and
neural development.
Tet3 Is an Active 5mC Hydroxylase that Regulates the
5mC/5hmC Status at Target Gene Promoters
As DNAmethylation at gene promoters has regulatory effects on
the expression of the associated genes, we asked whether Xen-
opus Tet3 modulates the 5mC/5hmC status at its target gene
promoters. To address this question, we first demonstrate that
Xenopus Tet3 has conserved 5mC hydroxylase activity as
mammalian Tet proteins. The xlTet3 catalytic domain (CD) can
convert 5mC to 5hmC in cells and in vitro (Figures 3A and 3B).
Utilizing two independent methods, anti-5hmC antibody-based
dot-blot and T4 Phage b-glucosyltransferase-mediated 5hmC
glucosylation assays, we demonstrate that 5hmC exists in the
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Figure 2. Tet3 Directly Regulates Key Developmental Genes
(A) Expression level changes of developmental genes resulting from Tet3 depletion as shown by in situ hybridization at stage 14. Red arrows show the inhibited
expression by xlTet3 MOs injection, whereas black arrows show rescued expression by xtTet3 coinjection. L, left; R, right; a, anterior; p, posterior; d, dorsal;
v, ventral. The red dots are injection tracer by b-gal staining.
(B) RT-qPCR confirms the differentially expressed genes after Tet3 depletion at stage 14. Control MO, xlTet3 MOs or xlTet3 MOs/xtTet3 was injected into two
dorsal blastomeres at 4-cell stage. Relative gene expression was normalized to odc. Results are shown as mean ± SD (n = 3).
(C) Tet3 occupancy at target gene promoters by ChIP-qPCR assay. Data are presented as mean ± SEM (n = 3).
See also Figure S2.genome of Xenopus embryos and is globally reduced after Tet3
depletion (Figure 3C). However, consistent with undetectable or
extremely low levels of 5fC and 5CaC in ES cells and varioustissues (Globisch et al., 2010; Ito et al., 2011), we failed to detect
5fC and 5CaC in Xenopus embryos (data not shown). Collec-
tively, these data suggest that Tet3 possesses intrinsic 5mCCell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc. 1203
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Figure 3. Tet3 Is an Active 5mC Hydroxylase Regulating the 5mC/5hmC Status at Target Gene Promoters
(A) xlTet3 CD is sufficient to convert 5mC to 5hmC in HEK293T cells by immunofluorescence analysis. Flag-tagged xlTet3 CD protein was detected using Flag
antibody.
(B) xlTet3a CD protein converts 5mC to 5hmC in vitro by dot-blot assay. Avidin-HRP is used to detect total biotin-labeled DNA, showing equal loading.
(C) Tet3 depletion results in globally decreased 5hmC in stage 14 embryos by dot-blot (left) and 5hmC glucosylation (right) assays. Open bar, control MO; filled
bar, xlTet3 MOs. Data are presented as mean ± SD (n = 3). **p < 0.01.
(D and E) hMeDIP-qPCR to detect dynamic 5hmC level changes in stage 10, 14, and 19 embryos. The targeting region for each primer set is underlined in (D).
Results are shown as mean ± SD (n = 3) in (E). *p < 0.05.
(F) Site-specific 5hmC level changes by Tet3 depletion in stage 14 embryos using the EpiMark 5mC/5hmC analysis kit. Open bar, control MO; filled bar, xlTet3
MOs. Red dot indicatesMspI/HapII recognition site and each PCR amplified region is underlined. Arrow denotes promoter orientation. Data are shown asmean ±
SD (n = 3). *p < 0.05.
(G) TAB-seq analyses of 5hmC status at the promoter of pax6 (left) and actc (right) in stage 14 embryos. The average percent at each CpG site is derived from
sequencing of 30–32 clones for pax6 promoter and 24–26 clones for actc promoter.
(H) Schematic diagram of hMeDIP-MeDIP strategy.
(I) hMeDIP-MeDIP qPCR to detect 5mC level changes after Tet3 depletion in stage 14 and 19 embryos. Data are shown as mean ± SD (n = 3). *p < 0.05. The
targeting region for each primer set is shown in (D).
See also Figure S3.
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hydroxylase activity and is, at least in part, responsible for modu-
lating 5hmC levels in Xenopus embryos.
We next asked whether Tet3 regulates 5hmC levels at target
gene promoters. We first examined the dynamic 5hmC level
changes by hydroxymethylated DNA immunoprecipitation
(hMeDIP)-qPCR (Xu et al., 2011b). Consistent with the increasing
Tet3 expression from stage 10 to 19 (Figure S1B), we observe
increasing 5hmC levels at a Tet3 target gene promoter, rx
promoter, but not at the nontargeted actc promoter (Figures
3D and 3E). Importantly, Tet3 depletion results in a significant
reduction in 5hmC at rx promoter at stages 14 and 19, thereby
significantly abolishing the increase in 5hmC from stage 10 to
14 to 19 (p < 0.05), whereas no 5hmC level changes are observed
at actc promoter (Figure 3E). However, we failed to detect 5hmC
level changes at other Tet3 target gene promoters including
pax6, six3, sox9, and ptc-2 by hMeDIP-qPCR perhaps due to
the low 5hmC levels at those promoters and the detection limits
of hMeDIP-qPCR. Thus, we applied amore sensitive CCGG site-
dependent strategy, EpiMark method (Ficz et al., 2011). As
exemplified by pax6 and ptc-2, depletion of Tet3 results in a
significant reduction in 5hmC at CCGG sites of both promoters
(p < 0.05), whereas no 5hmC changes are observed at the
nontargetedmyl2 and actc genes (Figure 3F). To next determine
the 5hmC status at multiple CpG sites, we employed the
newly developed Tet-assisted bisulfite sequencing (TAB-Seq)
approach (Yu et al., 2012), the most sensitive method to specif-
ically detect 5hmC at base-pair resolution. We first confirm that
more than 90% of 5mCs in the internal control DNA oligo have
been converted by TET1 CD (Figures S3A–S3C). Using pax6 as
an example, we clearly observe a significant decrease in 5hmC
at specific CpG sites within the pax6 promoter after Tet3 deple-
tion (p < 0.05 by one-way ANOVA), whereas the 5hmC levels at
actc promoter are not changed (Figure 3G), consistent with that
observed via the EpiMarkmethod. Taken together, by employing
multiple approaches to analyze changes in 5hmC at promoters
after Tet3 depletion, we demonstrate that Tet3 regulates the
5hmC status at its target gene promoters.
Finally, we addressed the extent to which 5hmC level
decrease by Tet3 depletion results in a subsequent 5mC level
increase. Notably, examining the alteration of 5mC directly re-
sulting from the change of 5hmC at Tet3 target gene promoters
is extremely technically challenging. Like most Xenopus genes,
Tet3 exhibits specific spatial-temporal expression in embryos
(Figures 1B–1E). Thus, changes in 5mC caused by Tet3 deple-
tion are expected to occur only in the small fraction of the
embryo expressing Tet3, whereas 5mC remains unchanged in
the rest of embryo, effectively diluting the signal from Tet3-ex-
pressing cells. Indeed, using the whole embryos, we attempted
and failed to detect 5mC changes after Tet3 depletion by
multiple approaches, such as methylated DNA immunoprecipi-
tation (MeDIP) and methylated CpG island recovery assay. We
therefore developed a targeting strategy, employing hMeDIP-
MeDIP qPCR to separate the signal from the noise and examine
the 5mC level changes directly resulting from 5hmC level
changes by Tet3 depletion (Figure 3H). We first performed
hMeDIP to enrich 5hmC-containing genomic DNA fragments
that presumably are from Tet-expressing cells. Given that Tet3
depletion results in a 5hmC level decrease but not completeremoval, Tet3-targeted DNAs in xlTet3 MOs-treated embryos
still contain 5hmC and can be enriched, albeit with a lower
amount than the control embryos. We then carried out MeDIP
by using the hMeDIPed DNA as input to examine relative 5mC
levels in those 5hmC-containing DNAs given the dynamic
conversion of 5mC to 5hmC and the coexistence of 5mC and
5hmC in the same region (Ficz et al., 2011; Yu et al., 2012). We
first confirm that the different amount of starting DNA (hMeDIPed
DNA) will not introduce a MeDIP efficiency bias, as validated by
the equal MeDIP enrichment of the human NBR2 promoter from
control DNA spiked in the hMeDIPed DNA from control MO- or
Tet3 MOs-injected embryos (Figure S3D). For proof-of-principle,
we examined the rx gene promoter because it has the most
dramatic changes in 5hmC after Tet3 depletion and can be easily
detected (Figure 3E). Indeed, we clearly observe a significant
5mC level increase at rx gene promoter after Tet3 depletion by
this hMeDIP-MeDIP qPCR method in stage 14 and 19 embryos
(Figure 3I), whereas the 5mC level at actc promoter is not
changed (Figure 3I), validating the reliability of hMeDIP-MeDIP
qPCR procedure. Thus, we conclude that Tet3 regulates target
gene expression, at least partially, through control of 5mC/
5hmC status at the promoter of target genes.
The Tet3 CXXC Domain Possesses Unique DNA Binding
Properties
In addition to the dioxygenase domain that confers 5mC
hydroxylase activity, Tet3 also contains a potential DNA binding
domain, the CXXC domain. In general, the selective DNA binding
activity of a transcription factor serves as a key mechanism for
action of the transcription factor in gene transcriptional regula-
tion. Sequence alignment indicates that Tet CXXC domains
exhibit a conserved overall structure with other CXXC domains
(Figure S4A). However, Tet CXXC domains lack a short se-
quence motif (KFGG) (Figure S4A), which has been shown to
be important for the DNA binding activity of the MLL and CFP1
CXXC domains (Allen et al., 2006; Xu et al., 2011a). To address
whether the Tet3 CXXC domain may possess unique DNA
binding features, we examined the DNA binding ability and
specificity of the Xenopus Tet3 CXXC domain (aa 58–111) by
isothermal titration calorimetry (ITC) assays. The Tet3 CXXC
domain strongly binds to various C/G-rich DNA oligos but
exhibits virtually no binding activity to the A/T-only DNA oligo
(Figures 4A–4E and Table S1, 1–8). Significantly, these ITC
results also reveal previously uncharacterized DNA binding
properties of the CXXC domain. First and most importantly, the
Tet3 CXXC domain strongly binds to both non-CpG (Table S1,
5–7) and CpGDNA oligos (Table S1, 1–4 and 9) with a slight pref-
erence for CpG DNA oligos. Second, the Tet3 CXXC domain
strongly binds to CmCGG DNA (Figure 4F and Table S1, 10).
These binding properties are in stark contrast to the well-charac-
terized DNA binding property of the CFP1 and MLL CXXC
domains, which absolutely require unmethylated CpG dinucleo-
tides (Allen et al., 2006; Xu et al., 2011a). In contrast to the strong
binding to CmCGG,CTAGandACGTDNAoligos, the Tet3CXXC
domain does not bind to mCmCGG, mCTAG, or AmCGT DNA
oligos (Figure 4G and Table S1, 11–13). These data suggest
that although strict CpG content is not required for the Tet3
CXXC domain to interact with DNA, an unmodified cytosine isCell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc. 1205
Figure 4. The Unique DNA Binding Properties of the Tet3 CXXC Domain
(A–H) Binding affinities of the Tet3 CXXC domain to various DNA oligos by ITC assays. The sequence of the central four nucleotides of each double-stranded DNA
probe is shown under the corresponding panel. Detailed sequence information for all DNA oligos used in this study is listed in Table S1. NB: no binding.
(I) Representative TET3 CXXC GST pull-down sequencing results. Arrow denotes promoter orientation.
(J) Genomic distribution of the TET3 CXXC-bound loci. Promoter is defined as 2 kb to +2 kb relative to transcription start site (TSS).
(K) The percentage of CpA, CpT, CpC, and CpG in human genome and the TET3 CXXC-bound loci.
(L) DNA motifs that are enriched in the TET3 CXXC-bound loci.
See also Figure S4 and Table S1.
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Table 1. Data Collection and Refinement Statistics
xtTet3 CXXC-
GCCAACGTTGGC
xtTet3 CXXC-
GCCACmCGGTGGC
PDB code 4HP3 4HP1
Space group C2 C2
Cell Dimensions
a, b, c (A˚) 69.9, 39.5, 54.1 71.0, 39.5, 57.6
a, b, g () 90, 99.9, 90 90, 91.0, 90
Resolution range (A˚) 34.42-2.05
(2.16-2.05)
35.51-2.25
(2.37-2.25)
Number of unique HKLs 9281 (1345) 7738 (1110)
Completeness (%) 99.8 (99.8) 99.9 (100.0)
Friedel redundancy 3.7 (3.7) 4.1 (4.2)
Rsym (%) 5.3 (66.9) 4.6 (48.7)
<I/s(I) > 12.6 (2.1) 14.7 (2.8)
Resolution limits (A˚) 30.00-2.05 35.00-2.25
Number of unique HKLs
work/free
8829/452 7385/351
Rwork/Rfree (%) 21.6/24.3 22.0/25.0
Number of
atoms/< B > (A˚2)
898/54.8 886/73.9
DNA 486/58.2 487/78.8
Protein 384/51.7 387/68.5
Zn2+ 2/33.2 2/46.8
RMSD bonds
(A˚)/angles ()
0.013/1.4 0.012/1.4
Ramachandran plot
favored residues, no
outliers (Lovell et al.,
2003)
47 of 49 48 of 49
RMSD is an abbreviation for root mean squared deviation. Average
B-factors calculated with MOLEMAN (G.J. Kleywegt, Uppsala Univer-
sity). The highest resolution shell is shown in parentheses.essential for the Tet3 CXXC binding to DNA. Using the same ITC
approach, we also demonstrate that the human TET3 CXXC
domain has similar DNA binding properties to the Xenopus
Tet3 CXXC domain (Table S1, 17–22). Thus, the CXXC domain
of the Tet3 family has unique newly identified DNA binding char-
acteristics conserved among vertebrates.
Given the similar binding properties between human and Xen-
opus Tet3 CXXC domains, we next determined the DNA binding
specificity of the TET3 CXXC domain across the whole genome
of HEK293T cells. The specific TET3 CXXC-bound genomic
DNA fragments were enriched by GST pull-downs and analyzed
by deep DNA sequencing, as we previously described (Xu et al.,
2011b). The TET3 CXXC domain selectively binds to restricted
genomic regions (Figure S4B). Importantly, consistent with
Tet3 occupancy in Xenopus embryos (Figure 2C), the TET3
CXXC domain strongly and selectively binds to the promoters
of PAX6, PTCH1, NGN2, TUBB2B, and SHH, but not the pro-
moter ofMYL2 (Figures 4I and S4C). Furthermore, bioinformatics
analyses identify 17,953 TET3 CXXC-bound peaks, more than
half of which are located at gene promoters (Figure 4J). Interest-
ingly, we also observe a significant enrichment of CpG (and a
less degree of CpC) dinucleotides in TET3 CXXC-bound regions
(Figure 4K). Further de novo motif discovery analyses identify
three C-rich sequences among the top 15 ranking motifs within
TET3 CXXC-bound regions (Figure 4L), whose consensus
sequences are SSGCSGCGCG (p = 13 1030), CSSCGCSCRC
(p = 3.47113 1026) and SCWGCWGCBS (p = 4.65633 1025),
respectively. Indeed, we validate that these motifs are present
at the promoters of several TET3 target genes (Figure S4D).
Together with the ITC binding data, these genome-wide anal-
yses suggest that the TET3 CXXC domain is able to bind to the
unmodified C followed by A, T, C, or G with a slight preference
for CpG dinucleotides. These data also indicate that the specific
DNA binding activity of the Tet3 CXXC domain may contribute to
Tet3 targeting, thereby serving as another important mechanism
for Tet3-mediated gene transcriptional regulation.
Crystal Structures of the Tet3 CXXCDomain in Complex
with DNA Oligos
To gain further mechanistic insight into the unique DNA binding
properties of the Tet3 CXXC domain, we next determined the
crystal structures of the Xenopus Tet3 CXXC domain (aa 58–
111) in complex with 5mC-containing DNA (CmCGG) and
CpG-containing DNA (ACGT), respectively (Table 1). Like other
CXXC domains, the Tet3 CXXC domain contains eight con-
served cysteine residues coordinating two zinc ions. These
two zinc ions play a structural role by holding the mainly unstruc-
tured CXXC domain together and forming a crescent-shaped
architecture to bind DNA (Figures 5A and 5C). The DNA-binding
surface is predominantly positively charged, and wedged into
the major groove of DNA to extensively interact with DNA bases
by means of hydrogen bonds and electrostatic interactions
(Figures 5A–5D).
Surprisingly, structural comparison of the Tet3 CXXC domain
in complex with CmCGG or ACGT DNA reveals that the Tet3
CXXC domain binds to the 12-mer target DNAs with one nucle-
otide shift. In the crystal structure of the Tet3 CXXC domain in
complex with the unmethylated CpG DNA (ACGT), the Tet3CXXC domain binds to the DNA centering on the cytosine in
the CpG dinucleotide (underlined). Methylation of the cytosine
in the CpG dinucleotides (CmCGG) shifts the binding to the cyto-
sine (underlined) preceding the mCpG dinucleotides. Therefore,
consistent with the ITC binding results, the Tet3 CXXC domain
binds to an unmodified cytosine, which is not restricted by
CpG content, distinct from the CpG-dependent binding of the
MLL, CFP1, and DNMT1CXXC domains (Allen et al., 2006; Prad-
han et al., 2008; Xu et al., 2011a).
In both Tet3 CXXC-ACGT and Tet3 CXXC-CmCGG complex
structures, the main chain carbonyl oxygen of residue His90
forms a hydrogen bond with the target cytosine, whereas the
side chain of His90 forms another hydrogen bond with the
complementary guanine (Figures 5E, 5G, S5A and S5C). In
the Tet3 CXXC-ACGT complex structure, residues Gln91 and
Ser89 form hydrogen bonds with the guanine-cytosine base
pair following the target cytosine-guanine base pair (Figures 5F
and S5B). In contrast, in the Tet3 CXXC-CmCGG complex struc-
ture, methylation of C6 introduces steric clashes with the side
chain of Gln91 and causes the side chain of Gln91 to become
partially disordered. As a result, Ser89 flips peptide plane andCell 151, 1200–1213, December 7, 2012 ª2012 Elsevier Inc. 1207
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Figure 5. The Tet3 CXXC Domain Specifically Recognizes Cytosine through a Conserved Residue His90
(A and C) Crystal structures of the Tet3 CXXC domain in complex with ACGT DNA (50-GCCAACGTTGGC-30) (A) or CmCGGDNA (50-GCCACmCGGTGGC-30) (C)
in cartoon (left) and electrostatic representations (right), respectively. The double-stranded DNA sequence is shown in the middle of each corresponding panel.
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loses its hydrogen bond interaction with DNA (Figures 5H
and S5D). These data provide structural explanations for the
binding to CmCGG DNA and the slight binding preference
for CpG compared to CpH DNAs (H = A, T, C, or 5mC).
Substituting the target cytosine with any other nucleotide or
5mC would introduce steric clashes with His90 (Figure S5E),
consistent with the undetectable binding of the Tet3 CXXC
domain to ATATDNA (Figure 4E). To determine the role of residue
His90 of Tet3, which is conserved among all Tet CXXC domains
(Figure S4A), we generated the Tet3 CXXC H90A mutant and
tested its DNA binding activities by ITC assay. As expected, the
Tet3 CXXC H90A mutant loses its DNA binding abilities (Table
S1, 14–15), supporting an essential role of His90 in DNA binding.
To further understand the novel DNA binding property of the
Tet3 CXXC domain, we superimposed the complex structures
of the Tet3 and CFP1 CXXC domains (Xu et al., 2011a) (Fig-
ure S6A). Although the Tet3 CXXC domain adopts a similar fold
to that of the CFP1 CXXC domain, the loop region preceding
His90 of Tet3 is dramatically different from that of CFP1 (Fig-
ure S6A). In the CFP1 CXXC domain, Asp189 forms three
hydrogen bonds with the backbone of Lys198, Ile199, and
Arg200, making the loop very rigid and only allowing CpG
binding (Xu et al., 2011a). Notably, this Asp residue is highly
conserved in the CXXC domains of CFP1, MLL, DNMT1, and
KDM2A (Figure S4A). However, the corresponding loop between
the a3 and a4 helices of the Tet3 CXXC domain is much shorter
andmore flexible due to lack of hydrogen bonds seen in the rigid
loop of the CFP1 CXXC domain (Figure S6A). Therefore, the
shorter and less rigid loop of the Tet3 CXXC domain can accom-
modate other nucleotides besides G, such as T, C, A, or 5mC,
following the target C, which confers cytosine-specific instead
of CpG-specific binding property. In addition, we also observe
that the Tet3 CXXC domain binds to TCGA andmCCGGDNA oli-
gos (Table S1, 2 and 9) with slightly weaker binding affinities
compared to other CpG DNA oligos (Table S1, 1, 3 and 4).
Although the methyl group of thymine or 5mC does not cause
any steric clash with the Tet3 CXXC domain, the hydrophobic
methyl group points to the solvent and no residues in the Tet3
CXXC domain can recognize and stabilize it, which is not ener-
getically favorable (Figures S6B–S6E). Taken together, the Tet3
CXXC domain binds to cytosine-containing DNA with a slight
preference for a G following the target cytosine and modestly
disfavoring a T or mC preceding the target cytosine.
Both 5mC Hydroxylase Activity and CXXC Domain-
Mediated Specific DNA Binding Are Required for Tet3
Function in Target Gene Regulation and Embryonic
Development
Having defined the regulation of 5mC/5hmC status at Tet3 target
gene promoters by the 5mC hydroxylase activity and the unique
DNAbinding properties of the Tet3 CXXCdomain, we next deter-(B and D) Detailed interactions between the Tet3 CXXC domain and ACGT DNA
bridge interaction; olive arrow, hydrogen bond interaction; yellow arrow, electros
(E and F) Detailed interactions between the Tet3 CXXC domain (blue cartoon) and
(G and H) Detailed interactions between the Tet3 CXXC domain (blue cartoon) and
cartoon).
See also Figures S5 and S6.mined the role of these two functional domains in Tet3 function.
We generated wild-type (xtTet3), CXXC-deleted (xtTet3DCXXC),
His90-to-Ala (xtTet3H90A), and iron binding site-disrupted cata-
lytically inactive (xtTet3DHD) xtTet3 expression constructs (Fig-
ure 6A). We confirm that both the wild-type and mutant xtTet3
proteins are properly expressed and localized to the nucleus
(Figures S7A and S7B) and that the 5mC hydroxylase activity is
retained in xtTet3DCXXC and xtTet3H90A but not in xtTet3DHD
(Figure S7B). We also performed ChIP-qPCR assays to compare
the occupancy of wild-type and mutant Tet3 proteins at target
gene promoters. Both the CXXCdomain deletion andH90A point
mutation abolish the occupancy of mutant proteins at target
gene promoters (Figures 6B and S7C), suggesting an essential
role of the CXXC domain-mediated DNA binding in Tet3 target-
ing to specific genes. Importantly, although both xtTet3 and
xtTet3DHD exhibit similar occupancy, coinjection of xtTet3, but
not xtTet3DHD, significantly rescues the decreased 5hmC levels
caused by Tet3 depletion at target gene promoters including the
rx gene promoter (Figure S7D), suggesting that the enzymatic
activity of Tet3 is primarily responsible for the dynamic regulation
of 5hmC at its target genes.
We next used these constructs to determine which domain(s)
are critical for Tet3 functions in vivo. We first employed a func-
tional domain rescue approach to interrogate the role of Tet3
catalytic domain using pax6 gene expression as a readout. The
expression of pax6 is completely rescued in 79% of xtTet3 coin-
jected embryos, whereas the complete rescue effect of xtTet3
DHD coinjection only reaches 37%, significantly lower than that
of xtTet3 coinjection (p < 0.01) (Figure 6C). These results are
corroborated by phenotypic rescues. Only 25% of embryos are
completely rescuedby xtTet3DHDcoinjection, againsignificantly
lower than that of xtTet3coinjection, inwhich62%arecompletely
rescued (p < 0.01) (Figure 6D). Thus, these data suggest that the
5mC hydroxylase activity of Tet3 not only controls the dynamics
of 5mC/5hmC at target gene promoters but is also required for
target gene regulation and biological function in early embryonic
development. Next, we employed the same strategy to examine
the importance of the CXXC domain/His90-mediated specific
DNA binding in Tet3 function. Strikingly, xtTet3 H90A or xtTet3
DCXXC coinjection shows no rescue effects on the inhibited
pax6 expression or developmental phenotypes caused by Tet3
depletion (Figure 6C and 6D), highlighting an essential role of
the CXXC domain-mediated DNA binding in Tet3 function in
target gene regulation and embryonic development.
DISCUSSION
In this study, we report that Xenopus Tet3 is a new class of tran-
scription regulator playing an essential role in early eye and
neural development by directly regulating a set of key genes crit-
ical for these developmental processes. We also uncover that(B) or between the Tet3 CXXC domain and CmCGG DNA (D). Red arrow, salt
tatic interaction.
the target CG pair (E) or the following GC pair (F) in the ACGT DNA (red cartoon).
the target CG pair (G) or the followingmCG pairs (H) in the CmCGGDNA (green
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CGroup Complete defect 
Partial  
defect Normal Total Note
1. uninjected 0% (n=0) 0% (n=0) 100% (n=183) 183
2. Control MO 0% (n=0) 0% (n=0) 100% (n=192) 192
3. xlTet3 MOs 85% (n=171) 11% (n=23) 4% (n=7) 201
4. xlTet3 MOs/xtTet3 20% (n=38) 18% (n=36) 62% (n=121) 195 **
5. xlTet3 MOs/xtTet3∆CXXC 80% (n=148) 12% (n=22) 8% (n=15) 185 #
6. xlTet3 MOs/xtTet3∆HD 39% (n=73) 36% (n=68) 25% (n=48) 189 **, #
7. xlTet3 MOs/xtTet3H90A 80% (n=151) 14% (n=27) 6% (n=12) 190 #
Phenotype rescue
pax6 gene expression rescue
desserppuSpuorG Partially suppressed Normal Total Note
1. Control MO 0% (n=0) 0% (n=0) 100% (n=31) 53
2. xlTet3 MOs 96% (n=53) 0% (n=0) 4% (n=2) 55
3. xlTet3 MOs/xtTet3 7% (n=4) 14% (n=8) 79% (n=44) 56 **
4. xlTet3 MOs/xtTet3∆CXXC 92% (n=50) 4% (n=2) 4% (n=2) 54 #
5. xlTet3 MOs/xtTet3∆HD 40% (n=21) 23% (n=12) 37% (n=19) 52 **, #
6. xlTet3 MOs/xtTet3H90A 93% (n=52) 2% (n=1) 5% (n=3) 52 #
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Figure 6. Both 5mC Hydroxylase Activity and the CXXC Domain Are Important for Tet3 Function
(A) Schematic representation of xtTet3 mutants.
(B) The CXXC domain deletion disrupts Tet3 occupancy at specific gene promoters by ChIP-qPCR assay. Data are presented as mean ± SEM (n = 3). *p < 0.05.
(C) Summarized results of five independent pax6 expression rescue experiments. ‘‘Suppressed’’ means significantly suppressed pax6 expression in posterior
and anterior neural plates; ‘‘Partially suppressed’’ means pax6 expression is detected but not intact in posterior and anterior neural plates; ‘‘Normal’’ means intact
pax6 expression in posterior and anterior neural plates. **p < 0.01 compared to xlTet3 MOs, # p < 0.01 compared to xlTet3 MOs/xtTet3.
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the dynamic regulation of 5mC/5hmC status at target gene
promoters is an important mechanism underlying Tet3-mediated
target gene regulation during embryonic development. The Tet3
CXXC domain-mediated specific DNA binding is essential for
targeting Tet3 to its target genes, thus, providing another layer
of regulation on the transcription of Tet3 target genes. Our find-
ings support a molecular model of Tet3 action in target gene
regulation that involves Tet3 binding to unmethylated cytosines
(with a slight preference for CpG content) at target gene pro-
moters through its CXXC domain and its intrinsic 5mC hydroxy-
lase activity converting adjacent 5mC to 5hmC, which is an inter-
mediate for further DNA demethylation (Figure 6E). Recruitment
to a specific gene promoter and subsequent conversion of 5mC
to 5hmC cooperatively activate the expression of Tet3 target
genes, including those identified key developmental genes, to
ensure normal and precisely regulated embryogenesis. Inactiva-
tion of either one of these functional domains therefore will have
adverse impact on Tet3 function. Notably, our data also show
that the catalytically inactive Tet3 mutant retains partial rescue
effects in vivo, suggesting potential enzymatic activity-indepen-
dent mechanisms, such as recruiting or interacting with other
transcription factors, may also contribute to the full function of
Tet3 in gene regulation (Figure 6E). Indeed, TET3 forms a stable
complex with several critical transcription factors and histone
modifiers (data not shown). It has also been shown that an
enzymatic activity-independent mechanism is involved in gene
regulation by Tet1 inmouse ES cells (Williams et al., 2011). More-
over, it has been suggested that 5hmC is a stable epigenetic
mark that participates in regulating gene expression through
unidentified mechanisms such as recruiting unidentified 5hmC
specific ‘‘readers’’ (Branco et al., 2012; Matarese et al., 2011).
Thus, this model does not exclude the possibility that Tet3 and
5hmC may participate in target gene regulation through this
yet to be identified regulatory circuit.
Unlikewell-characterizedDNAmethylation (5mC) andDNMTs,
themechanism bywhich 5hmC and the enzymatic activity of TET
proteins contribute to gene regulation has been elusive. Our find-
ings here offer a biologicalmodel demonstrating that thedynamic
regulation of 5mC/5hmC by the Tet family of 5mC hydroxylases
has an important role in gene regulation during early eye and
neural development.We show that Tet3 is an active 5mChydrox-
ylase highly expressed in the region of the developing brain, eye,
and spinal cord in Xenopus embryos. As exemplified by rx and
pax6, ourdataclearly show thatTet3 targetgeneshavesignificant
alterations in 5hmCstatus at their promoters after Tet3 depletion.
Importantly, 5hmC level alterations and dysregulated gene ex-
pression can be completely rescued by wild-type Tet3. Yet the
rescue effect by the catalytically inactive Tet3 mutant is signifi-
cantly impaired, highlighting the importance of 5mC hydroxylase
activity in Tet3 function. Furthermore, consistent with the eye(D) Summarized results of five independent phenotypic rescue experiments. ‘‘P
‘‘Complete defect’’ means abnormal head structure and no eye. **p < 0.01 comp
(E) A model of Tet3 action in gene transcription regulation. The Tet3 CXXC doma
motifs with a slight preference for G at ‘‘Y’’ position and amild disfavor for T or 5mC
Then, the 5mC hydroxylase activity of Tet3 converts adjacent 5mC to 5hmC, an in
CD: catalytic domain. Please refer to the related text for more details.
See also Figure S7.developmental phenotypes inXenopus, we find that homozygous
deletion of the Tet3 catalytic domain in pure B6 genetic back-
ground mice (Gu et al., 2011) results in eye-related phenotypes
including the eyelid open at birth (EOB) phenotype (data not
shown), suggesting an evolutionally conserved function in eye
development from vertebrate to mammals and the critical role
of the 5mC hydroxylase activity in Tet3 function. Taken together,
our study clearly indicates that precise regulation of thedynamics
ofDNAmodification status at specificgene loci byTet3-mediated
conversionof 5mC to5hmC is an important andconservedepige-
netic mechanism for target gene regulation.
How epigenetic enzymes are targeted and/or confined to their
functional sites is a fundamental question in understanding the
mechanism underlying epigenetic transcription regulation. In
this study, our biochemical characterizations reveal that the
Tet3 CXXC domain binds to DNA in a cytosine-dependent
manner with a slight preference for CpG dinucleotides, distinct
from the CpG-dependent binding of other well-characterized
CXXC domains. We also notice that the DNA binding property
of the Tet3 CXXC domain is different from that of the TET1
CXXC domain that binds to unmodified C or 5mC- or 5hmC-
modified CpG-rich DNA (Xu et al., 2011b), suggesting that Tet1
and Tet3 may have different functions in gene regulation besides
their distinct expression patterns during early embryonic devel-
opment (Tan and Shi, 2012). Moreover, our genome-wide
mapping and de novo motif analyses of the TET3 CXXC domain
binding sites strongly suggest that the TET3 CXXC domain
selectively binds to several consensus sequences, therefore
offering a mechanism for targeting Tet3 to its target genes.
Finally, the crystal structure analysis of the Tet3 CXXC domain
in complex with DNA provides the following structural mecha-
nisms underlying its novel DNA binding ability and specificity.
(1) It reveals that the major binding force of the Tet3 CXXC
domain to CmCGG DNA is through the specific interaction
between residue His90 and the unmethylated cytosine, which
explains why the Tet3 CXXC domain can still bind to partially
methylated DNA, as long as there is an unmethylated cytosine
available in the target sequence; (2) it explains the slight binding
preference of the Tet3 CXXC domain for CpG compared to CpH
(H = A, T, C, or 5mC) and the modest disfavor for a T or 5mC
preceding the target C, suggesting that sequences flanking the
target C contribute to the overall binding affinity and specificity
of the Tet3 CXXC domain.
The importance of this CXXC domain-mediated specific DNA
binding activity of Tet3 is further demonstrated in our functional
studies using the Tet3 mutants with the CXXC domain deletion
(DCXXC) or H90A point mutation. These mutants lose the
specific association with Tet3 target gene promoters and func-
tional rescue abilities in vivo. Taken together, our study reports
a novel DNA binding property and functionality of the CXXCartial defect’’ means mild abnormal head structure, small eyes or one eye;
ared to xlTet3 MOs, # p < 0.01 compared to xlTet3 MOs/xtTet3.
in specifically binds to unmodified cytosine (underlined)-containing sequence
at ‘‘X’’ position, targeting Tet3 to the promoter of target developmental genes.
termediate for further DNA demethylation, thus activates the gene expression.
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domain that is essential for Tet3 function both in gene regulation
and embryonic development. It not only provides a key mecha-
nistic layer of Tet3-mediated target gene regulation but also
significantly advances our current understanding of the molec-
ular and biological function of the Tet family CXXC domains.
Noteworthy, even though the CXXC domain is essential for tar-
geting Tet3 to specific genomic regions, we do not exclude the
involvement of other potential cellular mechanisms for targeting
or recruiting Tet3 to its functional sites. We favor the hypothesis
that Tet3 is likely in complex with many other cellular factors
including sequence-specific DNA binding transcription factors
and cofactors, to execute its molecular, cellular, and biological
functions. Therefore, the associated transcription factors may
in part coordinate with the Tet3 CXXC domain and enzymatic
activity and contribute to the overall mechanism of action of
Tet3 in gene regulation and embryonic development.
EXPERIMENTAL PROCEDURES
Embryo Manipulation and Microinjection
X. laevis eggs were artificially fertilized with testis homogenate and cultivated in
0.13 MMR as previously described (Sakano et al., 2010). Capped synthetic
mRNAswere generated by in vitro transcription with sp6 polymerase. Embryos
were transferred to 3% Ficoll 400 in 0.13 MMR and injected embryos were
cultured in 0.13 MMR until the desired stage. For phenotype experiments,
80 ng of xlTet3 MOs (40ng of each xlTet3 MO) or control MO were injected
into two dorsal blastomeres of 4-cell stage embryos. For phenotype rescue
experiments, 1 ng of mRNA was coinjected with 80 ng of xlTet3 MOs into two
dorsal blastomeres of 4-cell stage embryos. For pax6, rx, six3, sox2, otx2,
sox9, snail, tubb2b, and ngn2 in situ hybridization experiments, 160 ng of xlTet3
MOsorcontrolMOwere injected intoonedorsalblastomereof each4-cell stage
embryo. Because the expression of shh and ptc-1 is on themidline, for shh and
ptc-1 in situ hybridization experiments, two dorsal blastomeres of each 4-cell
stageembryowere injectedwith160ngof xlTet3MOsor controlMO. In all injec-
tion studies, 200 pg of nucb-gal RNA were coinjected as the injection tracer.
Crystallization
Each pair of single-stranded DNAs was mixed with a molar ratio of 1:1 and
annealed to form double-stranded DNAs. Before cocrystallization, purified
xtTet3 CXXC protein was mixed with different DNAs in a molar ratio of 1:1.2.
Crystals of xtTet3 CXXC in complex with ACGT DNA (GCCAACGTTGGC)
were obtained via sitting drop vapor diffusion; 1.0 ml of complex was mixed
with 1.0 ml of well solution containing 0.1 M HEPES (pH 7.5), 0.2 M NaCl,
30% PEG 1500, against 800 ml of reservoir buffer at 18C. Crystals grow to
a mountable size in 3 days. Crystals of xtTet3 CXXC in complex with CmCGG
DNA (GCCACmCGGTGGC) were obtained in a similar way in the buffer con-
taining 0.1 M HEPES (pH 7.5), 0.2 M NaCl, 30% PEG 1500, 5% MPD. Both
crystals were flash-frozen in liquid nitrogen directly without cryoprotectant.
ACCESSION NUMBERS
The sequences of Tet3 genes have been deposited into GeneBank under the
accession numbers of HQ220209 (human TET3), HQ423151 (mouse Tet3),
HQ220207, and HQ220208 (X. laevis Tet3), respectively. The structures of
Tet3 CXXC-DNA complexes have been deposited in the Protein Data Bank
under accession number 4HP1 and 4HP3. The TET3 CXXC GST pull-down
sequencing data have been deposited in GEO database under the accession
number GSE41551.
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